Brain Cancer Vaccine
Mesenchymal stem cells have antitumor effect in rat glioma model
Published in Vaccine Weekly, September 8th, 2004
"The prognosis of patients with malignant glioma is extremely poor, despite the extensive surgical treatment that they receive and recent improvements in adjuvant radio- and chemotherapy. In the present study, we propose the use of gene-modified mesenchymal stem cells (MSCs) as a new tool for gene therapy of malignant brain neoplasms. Primary MSCs isolated from Fischer 344 rats possessed excellent migratory ability and exerted inhibitory effects on the proliferation of 9L glioma cell in vitro," scientists in Japan report.
"We also confirmed the migratory...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-09-08)
More Articles from Vaccine Weekly
- Cancer Vaccine
Plasmid DNA in microparticles stimulates durable T cell responses - Haemophilus Vaccine
Synthetic polysaccharide vaccine against Haemophilus influenzae developed - Influenza Vaccine
Immunostimulant patch enhances immune responses to influenza virus vaccine - Malaria Vaccine
Plasmodium antigen region elicits antibodies reactive with placental isolate - AIDS/HIV Vaccine
Candidate HIV type 1 vaccines elicit long-term memory B-cell responses - AIDS/HIV Vaccine
Codon optimization of HIV Tat enhance cell-mediated immune responses - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
